These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23086228)

  • 1. LCL124, a cationic analog of ceramide, selectively induces pancreatic cancer cell death by accumulating in mitochondria.
    Beckham TH; Lu P; Jones EE; Marrison T; Lewis CS; Cheng JC; Ramshesh VK; Beeson G; Beeson CC; Drake RR; Bielawska A; Bielawski J; Szulc ZM; Ogretmen B; Norris JS; Liu X
    J Pharmacol Exp Ther; 2013 Jan; 344(1):167-78. PubMed ID: 23086228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial therapies improve the therapeutic efficacy of nanoliposomal ceramide for pancreatic cancer.
    Jiang Y; DiVittore NA; Kaiser JM; Shanmugavelandy SS; Fritz JL; Heakal Y; Tagaram HR; Cheng H; Cabot MC; Staveley-O'Carroll KF; Tran MA; Fox TE; Barth BM; Kester M
    Cancer Biol Ther; 2011 Oct; 12(7):574-85. PubMed ID: 21795855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide regulates gemcitabine-induced senescence and apoptosis in human pancreatic cancer cell lines.
    Modrak DE; Leon E; Goldenberg DM; Gold DV
    Mol Cancer Res; 2009 Jun; 7(6):890-6. PubMed ID: 19531570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic long-chain ceramide LCL-30 induces cell death by mitochondrial targeting in SW403 cells.
    Dindo D; Dahm F; Szulc Z; Bielawska A; Obeid LM; Hannun YA; Graf R; Clavien PA
    Mol Cancer Ther; 2006 Jun; 5(6):1520-9. PubMed ID: 16818511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrion interfering compound NPC-26 exerts potent anti-pancreatic cancer cell activity in vitro and in vivo.
    Dong YY; Zhuang YH; Cai WJ; Liu Y; Zou WB
    Tumour Biol; 2016 Nov; 37(11):15053-15063. PubMed ID: 27658776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucin production determines sensitivity to bortezomib and gemcitabine in pancreatic cancer cells.
    Wissniowski TT; Meister S; Hahn EG; Kalden JR; Voll R; Ocker M
    Int J Oncol; 2012 May; 40(5):1581-9. PubMed ID: 22266985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bmi1 inhibition enhances the sensitivity of pancreatic cancer cells to gemcitabine.
    Yin T; Zhang Z; Cao B; Duan Q; Shi P; Zhao H; Camara SN; Shen Q; Wang C
    Oncotarget; 2016 Jun; 7(24):37192-37204. PubMed ID: 27177084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
    Chen H; Wei W; Guo Y; Liu A; Tong H; Wang Z; Tan W; Liu J; Lin S
    Oncol Rep; 2011 May; 25(5):1253-61. PubMed ID: 21305255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay between autophagy and apoptosis in pancreatic tumors in response to gemcitabine.
    Papademetrio DL; Cavaliere V; Simunovich T; Costantino S; Campos MD; Lombardo T; Kaiser CM; Alvarez E
    Target Oncol; 2014 Jun; 9(2):123-34. PubMed ID: 23588416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer.
    Cieslak JA; Strother RK; Rawal M; Du J; Doskey CM; Schroeder SR; Button A; Wagner BA; Buettner GR; Cullen JJ
    Free Radic Biol Med; 2015 Jun; 83():227-37. PubMed ID: 25725418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smac modulates chemosensitivity in head and neck cancer cells through the mitochondrial apoptotic pathway.
    Sun Q; Zheng X; Zhang L; Yu J
    Clin Cancer Res; 2011 Apr; 17(8):2361-72. PubMed ID: 21242120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance of pancreatic cancer to gemcitabine treatment is dependent on mitochondria-mediated apoptosis.
    Schniewind B; Christgen M; Kurdow R; Haye S; Kremer B; Kalthoff H; Ungefroren H
    Int J Cancer; 2004 Mar; 109(2):182-8. PubMed ID: 14750167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antitumor activity of a novel cationic pyridinium-ceramide alone or in combination with gemcitabine against human head and neck squamous cell carcinomas in vitro and in vivo.
    Senkal CE; Ponnusamy S; Rossi MJ; Sundararaj K; Szulc Z; Bielawski J; Bielawska A; Meyer M; Cobanoglu B; Koybasi S; Sinha D; Day TA; Obeid LM; Hannun YA; Ogretmen B
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1188-99. PubMed ID: 16510697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
    Guillermet-Guibert J; Davenne L; Pchejetski D; Saint-Laurent N; Brizuela L; Guilbeau-Frugier C; Delisle MB; Cuvillier O; Susini C; Bousquet C
    Mol Cancer Ther; 2009 Apr; 8(4):809-20. PubMed ID: 19372554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer.
    Hashim YM; Vangveravong S; Sankpal NV; Binder PS; Liu J; Goedegebuure SP; Mach RH; Spitzer D; Hawkins WG
    J Exp Clin Cancer Res; 2017 Jan; 36(1):14. PubMed ID: 28095907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periostin promotes the chemotherapy resistance to gemcitabine in pancreatic cancer.
    Liu Y; Li F; Gao F; Xing L; Qin P; Liang X; Zhang J; Qiao X; Lin L; Zhao Q; Du L
    Tumour Biol; 2016 Nov; 37(11):15283-15291. PubMed ID: 27696296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic interaction between sphingomyelin and gemcitabine potentiates ceramide-mediated apoptosis in pancreatic cancer.
    Modrak DE; Cardillo TM; Newsome GA; Goldenberg DM; Gold DV
    Cancer Res; 2004 Nov; 64(22):8405-10. PubMed ID: 15548711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy of gemcitabine and lidamycin associated with NF-kappaB downregulation in pancreatic carcinoma cells.
    Chen J; Wu SY; Ou-Yang ZG; Zhen YS
    Acta Pharmacol Sin; 2008 May; 29(5):614-9. PubMed ID: 18430374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
    Thoennissen NH; Iwanski GB; Doan NB; Okamoto R; Lin P; Abbassi S; Song JH; Yin D; Toh M; Xie WD; Said JW; Koeffler HP
    Cancer Res; 2009 Jul; 69(14):5876-84. PubMed ID: 19605406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer.
    Bao GQ; Shen BY; Pan CP; Zhang YJ; Shi MM; Peng CH
    Toxicol Lett; 2013 Sep; 222(1):23-35. PubMed ID: 23845849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.